Phase IV-An Open-Label Prospective Study of Memantine in Institutionalized Patients With Severe Alzheimer's Disease and Significant Behavioural and Psychological Symptoms of Dementia.
Phase of Trial: Phase IV
Latest Information Update: 24 May 2012
At a glance
- Drugs Memantine (Primary)
- Indications Aggression; Agitation
- Focus Therapeutic Use
- 02 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Dec 2009 Status changed from not yet recruiting to recruiting.
- 05 Dec 2006 New trial record.